| UNIQURE N.V. EO -,05 |
| Niederlande |
| Gesundheit |
| NL0010696654 / A1XDTV |
| UQ1 (Frankfurt) / QURE (NASDAQ) |
| FRA:UQ1, ETR:UQ1, UQ1:GR, NASDAQ:QURE |
| - |
| https://www.uniqure.com/ |
|
uniQure N.V. is a biopharmaceutical company based in the Netherlands, specializing in the discovery, development, and commercialization of innovative gene therapies for patients with severe genetic and neurological disorders. It leverages a proprieta..
>Volltext.. |
| 1448.91 Mio. EUR |
| 1413.51 Mio. EUR |
| 15.63 Mio. EUR |
| -157.76 Mio. EUR |
| -180.46 Mio. EUR |
| -3.03 EUR |
| 471.43 Mio. EUR |
| 120.95 Mio. EUR |
| -153.51 Mio. EUR |
| 9.91 |
| -16.13% |
| 10.11% |
| - |
| - |
| - |
| UNIQURE |
| 13.06.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|